Skip to main content
. 2021 Nov 17;11:769295. doi: 10.3389/fonc.2021.769295

Figure 4.

Figure 4

Temporal trend of the patient effective doses. The median E-value was about 2.6 mSv in the first 8 months of examinations with the standard protocol and about 1.5 mSv after the introduction of the optimized protocol.